The genomics research company took its overall funding to $300m in a series B round featuring Celgene, existing investor Illumina and corporate venturing unit GE Ventures.

Novo and existing investor AstraZeneca contributed to a round that will support Entasis Therapeutics' anti-infectives pipeline.

A total of 10 digital health startups stand to benefit from a three-month program supported by Arvato CRM Healthcare, Sanofi in Germany, Munich Health and ApoBank.

The diagnostics platform developer, spun out of Tufts University, secures additional capital from a consortium featuring the institution.

Alzheimer's drug company Chase Pharmaceuticals has added $12m to its funding total, which is likely to have included $3m from existing investor Cipla.

Providence Health & Services led a funding round for the surgical blood loss monitoring platform that also featured corporate-backed Summation Health Ventures.

Immuno-oncology company Immunexcite will use the funding, provided by backers including Sanofi and Partners Healthcare, to choose a lead program for clinical studies.

The Harvard spinout has raised a second funding round that included existing shareholder Cedars-Sinai, boosting its total equity funding to $40m.